These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2661475)

  • 1. [Prevention with thrombocyte aggregation inhibitors in cardiovascular indications].
    Lorenz R
    Internist (Berl); 1989 May; 30(5):315-21. PubMed ID: 2661475
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy--Part I.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies: evidence for intervention with specific antiplatelet drugs in arterial thromboembolism.
    Turpie AG
    Semin Thromb Hemost; 1988 Jan; 14(1):41-9. PubMed ID: 3281264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational therapeutics at the platelet vascular interface. Summary.
    FitzGerald GA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy in the prevention of cardiovascular diseases.
    Mannucci PM; Cimminiello C; Cattaneo M
    Ann Ital Med Int; 1993; 8(3):189-94. PubMed ID: 8217485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies of the effectiveness of aspirin in the prevention of major cardio-cerebrovascular occurrences].
    Mariani M; Biadi O
    Cardiologia; 1995 Dec; 40(12 Suppl 1):423-8. PubMed ID: 8998750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [-New aspects in antithrombotic therapy--platelet inhibitors-].
    Terres W; Meinertz T
    Herz; 1996 Feb; 21(1):1-11. PubMed ID: 8647575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tirofiban in acute coronary syndromes.
    Gomma A; Collinson J; Purcell H; Flather M
    Int J Clin Pract; 2000 Mar; 54(2):121-4. PubMed ID: 10824369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of unstable coronary disease].
    Préda I
    Orv Hetil; 2002 Apr; 143(15):757-65. PubMed ID: 11979994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-aggregating agents: for which patients?].
    Nicolas G
    Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):623-7. PubMed ID: 3548564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet function testing in cardiovascular diseases.
    Michelson AD
    Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing unstable angina in high-risk patients.
    Chew DP; Moliterno DJ
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():31A-48A. PubMed ID: 11847404
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy for ischemic heart disease in the elderly.
    Frishman WH; Miller KP
    Geriatrics; 1988 Dec; 43 Suppl():46-56. PubMed ID: 3056785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abciximab and percutaneous coronary intervention: new indications. Medium-term benefit.
    Prescrire Int; 2000 Apr; 9(46):36-8. PubMed ID: 11503782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.
    De Caterina R
    Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.